Bristol-Myers Squibb Co. (BMY) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $59.12 -0.77%
Revenue Growth %: +3.4%
Financial Fact:
Net Sales: 4.92B
Today's EPS Names:
HOVR, VFS, PGR, More
Revenue Growth %: +3.4%
Financial Fact:
Net Sales: 4.92B
Today's EPS Names:
HOVR, VFS, PGR, More
Join SI Premium – FREE
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q2 EPS of $0.48, $0.04 better than the analyst estimate of $0.44. Revenue for the quarter came in at $3.89 billion versus the consensus estimate of $3.85 billion.
Bristol-Myers Squibb Co. reaffirmed FY2014 guidance.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top AI Semiconductor Stocks According to Stifel Analysis
- Hunterbrook discloses Meta short position as alternative data signals Muse cooling
- SpaceX's spectrum deal puts SIRI's satellite assets in focus
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
